Buys | $0 | 0 | 0 |
Sells | $4,498,017 | 19 | 100 |
Liawatidewi Yakob | EVP CORP ADMIN CENTER | 0 | $0 | 1 | $271,389 | $-271,389 |
Petersen Floyd F. | director | 0 | $0 | 6 | $355,481 | $-355,481 |
PETERS WILLIAM J | CFO, EVP & TREASURER | 0 | $0 | 4 | $1.1M | $-1.1M |
Zhou Rong | SENIOR EVP, PRODUCTION CENTER | 0 | $0 | 5 | $1.35M | $-1.35M |
PRINS RICHARD K | director | 0 | $0 | 3 | $1.42M | $-1.42M |
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for …
Over the last 12 months, insiders at Amphastar Pharmaceuticals, Inc. have bought $0 and sold $4.5M worth of Amphastar Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Amphastar Pharmaceuticals, Inc. have bought $40,520 and sold $15.1M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $40,520 was made by Maris David (director) on 2020‑08‑14.
2025-03-06 | Sale | Petersen Floyd F. | director | 1,000 0.0021% | $27.99 | $27,986 | -0.11% | |
2025-03-04 | Sale | PETERS WILLIAM J | CFO, EVP & TREASURER | 4,231 0.0088% | $27.54 | $116,515 | +2.43% | |
2024-12-13 | Sale | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | 8,000 0.018% | $45.23 | $361,840 | -23.37% | |
2024-12-12 | Sale | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | 7,000 0.0145% | $44.42 | $310,975 | -26.79% | |
2024-12-09 | Sale | PRINS RICHARD K | director | 10,000 0.0207% | $43.77 | $437,702 | -25.19% | |
2024-11-12 | Sale | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | 6,893 0.0147% | $48.88 | $336,930 | -24.25% | |
2024-11-12 | Sale | PRINS RICHARD K | director | 5,000 0.0107% | $48.80 | $243,986 | -24.25% | |
2024-11-06 | Sale | PETERS WILLIAM J | CFO, EVP & TREASURER | 7,426 0.0148% | $52.05 | $386,523 | -32.02% | |
2024-11-06 | Sale | Liawatidewi Yakob | EVP CORP ADMIN CENTER | 5,214 0.0104% | $52.05 | $271,389 | -32.02% | |
2024-09-13 | Sale | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | 3,000 0.0062% | $48.26 | $144,785 | -18.09% | |
2024-09-05 | Sale | Petersen Floyd F. | director | 3,000 0.0063% | $46.47 | $139,417 | -10.06% | |
2024-08-26 | Sale | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | 4,000 0.0083% | $48.35 | $193,400 | -9.43% | |
2024-08-12 | Sale | PRINS RICHARD K | director | 17,101 0.0347% | $43.07 | $736,550 | +1.31% | |
2024-07-31 | Sale | PETERS WILLIAM J | CFO, EVP & TREASURER | 10,282 0.0214% | $44.23 | $454,773 | +0.21% | |
2024-06-27 | Sale | PETERS WILLIAM J | CFO, EVP & TREASURER | 3,596 0.0075% | $40.93 | $147,169 | +4.44% | |
2024-06-10 | Sale | Petersen Floyd F. | director | 3,000 0.0061% | $41.40 | $124,200 | -1.92% | |
2024-06-03 | Sale | Petersen Floyd F. | director | 500 0.001% | $42.65 | $21,326 | -3.20% | |
2024-05-01 | Sale | Petersen Floyd F. | director | 500 0.001% | $41.67 | $20,837 | +0.10% | |
2024-04-01 | Sale | Petersen Floyd F. | director | 500 0.001% | $43.43 | $21,714 | -4.22% | |
2024-03-06 | Sale | PETERS WILLIAM J | CFO, EVP & TREASURER | 18,136 0.0379% | $46.48 | $842,883 | -8.69% |
Petersen Floyd F. | director | 74409 0.1562% | $2.16M | 1 | 60 | +27.09% |
PRINS RICHARD K | director | 30471 0.0639% | $883,354.29 | 2 | 42 | +28.12% |
Zhang Jack Y. | CEO & Chief Scientific Officer | 6827679 14.3288% | $197.93M | 2 | 35 | +24.35% |
Koo Richard | director | 253270 0.5315% | $7.34M | 1 | 3 | +27.09% |
Lee Howard | director | 142939 0.3% | $4.14M | 1 | 18 | +18.46% |
$910,099,463 | 123 | 11.52% | $2.38B | |
$187,390,806 | 89 | 12.63% | $808.7M | |
$12,681,496 | 70 | 20.90% | $756.61M | |
$23,522,750 | 59 | -6.74% | $5.19B | |
$14,599,168 | 59 | 12.79% | $1.46B |
Increased Positions | 123 | +36.07% | 4M | +12.11% |
Decreased Positions | 150 | -43.99% | 4M | -11.63% |
New Positions | 38 | New | 1M | New |
Sold Out Positions | 50 | Sold Out | 1M | Sold Out |
Total Postitions | 314 | -7.92% | 36M | +0.47% |
Blackrock, Inc. | $173,930.00 | 12.75% | 6.12M | +85,100 | +1.41% | 2024-12-31 |
Vanguard Group Inc | $77,177.00 | 5.66% | 2.71M | +3,155 | +0.12% | 2024-12-31 |
Td Asset Management Inc | $52,319.00 | 3.83% | 1.84M | -294,752 | -13.8% | 2024-12-31 |
State Street Corp | $45,377.00 | 3.33% | 1.6M | +65,646 | +4.29% | 2024-12-31 |
Neuberger Berman Group Llc | $39,066.00 | 2.86% | 1.37M | -240,963 | -14.92% | 2024-12-31 |
Pacer Advisors, Inc. | $38,391.00 | 2.81% | 1.35M | +1M | +51,977.44% | 2024-12-31 |
Dimensional Fund Advisors Lp | $34,076.00 | 2.5% | 1.2M | +105,288 | +9.63% | 2024-12-31 |
Fuller & Thaler Asset Management, Inc. | $32,209.00 | 2.36% | 1.13M | -127,841 | -10.14% | 2024-12-31 |
Epoch Investment Partners, Inc. | $31,309.00 | 2.29% | 1.1M | -89,837 | -7.54% | 2024-12-31 |
Boston Trust Walden Corp | $27,831.00 | 2.04% | 978,920 | +439,281 | +81.4% | 2024-12-31 |